ACRV earnings: next report 2026-08-12, real EPS beat/miss history, analyst consensus Buy, P/E -0.84. Updated 2026-07-23.
Acrivon Therapeutics, Inc. Common Stock (ACRV) Research Hub
Acrivon Therapeutics, Inc. Common Stock (ACRV) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2 USD (+0.50%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.84, market cap 0.05B. This hub links to the full technical, earnings and options research available for ACRV.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2 USD (+0.50%) |
| 52-week range | 1.41 USD – 2.39 USD |
| Trend regime | Range |
| 14-day RSI | 61 (Bullish) |
| Trailing P/E | -0.84 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for ACRV
Covered Call on ACRV: how it works, illustrative setup around the real 2 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ACRV: how it works, illustrative setup around the real 2 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ACRV: how it works, illustrative setup around the real 2 USD price, max profit/loss, breakeven and when to use it. Educational.
ACRV technical analysis: range, last 2 USD, RSI 61, 52w range 1.41 USD–2.39 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ACRV in?
Acrivon Therapeutics, Inc. Common Stock (ACRV) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ACRV in an uptrend or downtrend?
As of 2026-09-11, ACRV is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ACRV's trailing P/E ratio?
ACRV's trailing P/E is -0.84, with a market cap of 0.05B. See the earnings research page for full valuation detail.
When does ACRV next report earnings?
ACRV is next scheduled to report earnings on 2026-08-12, with a consensus EPS estimate of -0.49 USD.